Which has grown faster, MRNA or UTHR?

Over the past five years, UTHR grew revenue faster — MRNA at a -2.60% CAGR versus UTHR at 16.05%.

Is MRNA or UTHR more profitable?

UTHR runs the higher net margin — MRNA at -143.55% versus UTHR at 40.61%.

Which has been the better investment, MRNA or UTHR?

Over the past 5-year, UTHR delivered the higher annualized total return — MRNA at -25.58% versus UTHR at 17.22%. Past performance doesn't predict future results.

Moderna, Inc. (MRNA) vs United Therapeutics Corporation (UTHR)

UTHR leads on 8 of 10 compared metrics.

A side-by-side comparison of Moderna, Inc. and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

United Therapeutics Corporation

$23.17B

$545.96Healthcare

Total return — MRNA vs UTHR

growth of $100 · last 8y

MRNA +165.5%UTHR +403.2%UTHR compounded faster

MRNA UTHR

MRNA vs UTHR: by the numbers

•UTHR is the larger company ($23.17B vs $19.80B market cap).
•UTHR is profitable (40.61% net margin) while MRNA runs a net loss (-143.55%).
•UTHR grew revenue faster over the past five years (16.05% vs -2.60% CAGR).

Which is better, MRNA or UTHR?

Metric tally: MRNA 2 · UTHR 8

It depends on what you're optimizing for:

GrowthUTHR(faster 5Y revenue CAGR)

QualityUTHR(higher ROIC)

Valuation

Metric	MRNA	UTHR
P/E ratio	—	20.18
Forward P/E	—	16.48
P/S ratio	8.86	8.13●
P/B ratio	2.66●	4.37
PEG ratio	—	1.16
EV / EBITDA	—	14.41
FCF yield	—	3.95%

Profitability

Metric	MRNA	UTHR
Gross margin	-13.89%	86.58%●
Operating margin	-153.35%	45.34%●
Net margin	-143.55%	40.61%●
ROE	-43.12%	21.82%●
ROIC	-29.70%	16.14%●

Growth (annualized)

Metric	MRNA	UTHR
Revenue CAGR (5Y)	-2.60%	16.05%●
EPS CAGR (5Y)	—	20.93%
FCF CAGR (5Y)	126.92%●	12.12%
Total return CAGR (5Y)	-25.58%	24.96%●

Frequently asked

Which is better, MRNA or UTHR?: It depends on your goal. growth: UTHR (faster 5Y revenue CAGR); quality: UTHR (higher ROIC). Across all compared metrics, UTHR leads 8 to 2.
Which has grown faster, MRNA or UTHR?: Over the past five years, UTHR grew revenue faster — MRNA at a -2.60% CAGR versus UTHR at 16.05%.
Is MRNA or UTHR more profitable?: UTHR runs the higher net margin — MRNA at -143.55% versus UTHR at 40.61%.
Which has been the better investment, MRNA or UTHR?: Over the past 5-year, UTHR delivered the higher annualized total return — MRNA at -25.58% versus UTHR at 17.22%. Past performance doesn't predict future results.

Go deeper

Full MRNA analysis Full UTHR analysis Interactive comparison tool

Dig into the metrics

Moderna P/E ratio United Therapeutics P/E ratio Moderna dividend yield United Therapeutics dividend yield Moderna ROE United Therapeutics ROE Moderna operating margin United Therapeutics operating margin Moderna revenue growth United Therapeutics revenue growth Moderna free cash flow United Therapeutics free cash flow

Moderna & United Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.